Tetraphase Pharmaceuticals (TTPH) PT Lowered to $6 at B.Riley/FBR, 'IGNITE3 Failure Limits but Does Not Quash Eravacycline Opportunity'
Tweet Send to a Friend
B.Riley/FBR lowered its price ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
